New pain pill SBS-147 enters first human safety trial
NCT ID NCT07335913
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests the safety of an experimental pain drug called SBS-147 in 80 healthy adults. Some participants get the drug, others a placebo. The study has two parts: a single dose group and a group that takes the drug daily for a week. Researchers will monitor side effects and how the body processes the drug. This is a first step to see if SBS-147 is safe enough for future pain studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SBS-147 (experimental drug)
What this could lead to
If safe and well-tolerated, this could lead to further studies testing SBS-147 as a new treatment for acute pain.
What could go wrong
This is a very early Phase 1 trial in healthy people, not patients with pain. It only checks safety and how the drug is processed, not whether it actually relieves pain. Side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AltaSciences, Inc
RECRUITINGCypress, California, 90630, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••